CIK 0000727510
- Non-accelerated filer
- Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222372868
- Phone
- +1 630-874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-05-09 | Renfro Phillip M Director | Sale | −3,600 | $9.45 | $34K | 1,911 |
| 2008-05-09 | Renfro Phillip M Director | Sale | −1,887 | $9.47 | $18K | 24 |
| 2008-01-17 | TOOMAN CRAIG A EVP, FINANCE, CFO | Grant or award | +55,000 | 109,500 | ||
| 2008-01-17 | HORAK IVAN D EVP, R&D, Chief Scientific Ofc | Grant or award | +55,000 | 91,000 | ||
| 2008-01-17 | BUCHALTER JEFFREY H Chairman, CEO & President | Grant or award | +200,000 | 403,234 | ||
| 2008-01-17 | Davit Paul Stephen EVP, Human Resources | Grant or award | +10,000 | 50,656.17 | ||
| 2008-01-17 | del Campo Ralph EVP, Technical Operations | Grant or award | +55,000 | 114,156.14 | ||
| 2008-01-02 | SALISBURY ROBERT C Director | Grant or award · Stock Option (Right to Buy) | +21,227 | 21,227 |
Page 25 of 25 · 488 trades